The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | R | Respiratory system | |
| 2 | R06 | Antihistamines for systemic use | |
| 3 | R06A | Antihistamines for systemic use | |
| 4 | R06AE | Piperazine derivatives | |
| 5 | R06AE03 | Cyclizine |
The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.
| Route | Amount |
|---|---|
| ORAL - Oral | 0.1 g |
| RECTAL - Rectal | 0.3 g |
| Active Ingredient | Description | |
|---|---|---|
| Cyclizine |
Cyclizine is a histamine H1 receptor antagonist of the piperazine class which is characterised by a low incidence of drowsiness. It possesses anticholinergic and antiemetic properties. The exact mechanism by which cyclizine can prevent or suppress both nausea and vomiting from various causes is unknown. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| VALOID Solution for injection | Health Products Regulatory Authority (IE) | MPI, EU: SmPC | |
| VALOID Tablet | Health Products Regulatory Authority (IE) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
